↓ Skip to main content

Melanoma

Overview of attention for book
Attention for Chapter 14: Acral Lentiginous Melanoma
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#39 of 168)
  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
125 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Acral Lentiginous Melanoma
Chapter number 14
Book title
Melanoma
Published in
Cancer treatment and research, January 2016
DOI 10.1007/978-3-319-22539-5_14
Pubmed ID
Book ISBNs
978-3-31-922538-8, 978-3-31-922539-5
Authors

James S. Goydos, Steven L. Shoen, Goydos, James S., Shoen, Steven L.

Abstract

Acral lentiginous melanoma (ALM) is a rare subtype of melanoma mainly arising on the palms, soles, and nail beds. ALM is the most common subtype of melanoma found in patients of Asian or African descent and tends to more advanced at presentation due to delays in diagnosis. Surgical treatment is difficult owing to the complexity and functional importance of the hands and feet and reconstruction after resection is usually needed. The prognosis for patients with ALM depends on stage of disease and tends to be worse than with other subtypes of melanoma. Newer treatment modalities such as immunotherapies and targeted agents are being tested in patients with advanced ALM with some promising preliminary results.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 125 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 13 10%
Student > Bachelor 13 10%
Student > Master 12 10%
Student > Doctoral Student 10 8%
Student > Ph. D. Student 10 8%
Other 25 20%
Unknown 42 34%
Readers by discipline Count As %
Medicine and Dentistry 51 41%
Biochemistry, Genetics and Molecular Biology 12 10%
Nursing and Health Professions 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Unspecified 2 2%
Other 7 6%
Unknown 45 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2023.
All research outputs
#7,731,085
of 23,504,445 outputs
Outputs from Cancer treatment and research
#39
of 168 outputs
Outputs of similar age
#125,016
of 396,879 outputs
Outputs of similar age from Cancer treatment and research
#5
of 25 outputs
Altmetric has tracked 23,504,445 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 168 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.